These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Management of Hepatocellular Carcinoma: Current Status and Future Directions. Au JS; Frenette CT Gut Liver; 2015 Jul; 9(4):437-48. PubMed ID: 26087860 [TBL] [Abstract][Full Text] [Related]
25. Multidisciplinary treatment of patients with hepatocellular carcinoma. Masaki T; Morishita A; Kurokohchi K; Kuriyama S Expert Rev Anticancer Ther; 2006 Oct; 6(10):1377-84. PubMed ID: 17069523 [TBL] [Abstract][Full Text] [Related]
26. The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors. Gannon CJ; Curley SA Semin Radiat Oncol; 2005 Oct; 15(4):265-72. PubMed ID: 16183480 [TBL] [Abstract][Full Text] [Related]
27. [Transarterial chemoembolization and conformal radiotherapy for hepatocellular carcinoma]. Merle P; Mornex F Cancer Radiother; 2011 Feb; 15(1):69-71. PubMed ID: 21237690 [TBL] [Abstract][Full Text] [Related]
28. Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation. Takeda A; Sanuki N; Tsurugai Y; Iwabuchi S; Matsunaga K; Ebinuma H; Imajo K; Aoki Y; Saito H; Kunieda E Cancer; 2016 Jul; 122(13):2041-9. PubMed ID: 27062278 [TBL] [Abstract][Full Text] [Related]